Literature DB >> 2247036

Approaches for assessing the validity of a functional observational battery.

V C Moser1.   

Abstract

As neurobehavioral assessments during the preliminary stages of chemical testing are more widely undertaken, it is critical that the screening procedures utilized be valid indicators of neurobehavioral function and that they be sensitive, specific, and reliable. Efforts in this laboratory have been directed towards assessing these features in the use of a functional observational battery (FOB). For the purpose of assessing validity, we have examined FOB data which addresses the issues of criterion, predictive, concurrent, and construct validities. The FOB appears to be valid for detecting chemical-induced neurological dysfunction in rats, i.e., shows a good degree of criterion validity. Furthermore, in many instances the effects observed with the FOB may be predictive of symptomatology in humans. When comparisons can be made between effects detected with the FOB and other methods of measuring neurotoxicity (e.g., neuropathology), concurrent validity can also be established. To assess construct validity, effects of neurotoxicants can be classified into functional domains which are described by various measures in the FOB. Approaches for assessing the validity of the test method thus include answering specific research questions directed at assessing criterion, predictive, concurrent, and construct validity. Available data indicate that, in these aspects, the FOB is a valid screening method for the detection of neurotoxicity.

Entities:  

Mesh:

Year:  1990        PMID: 2247036     DOI: 10.1016/0892-0362(90)90011-z

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  7 in total

1.  Low dose of donepezil improves gabapentin analgesia in the rat spared nerve injury model of neuropathic pain: single and multiple dosing studies.

Authors:  Anna Folkesson; Per Hartvig Honoré; Lene Munkholm Andersen; Pernille Kristensen; Ole J Bjerrum
Journal:  J Neural Transm (Vienna)       Date:  2010-10-02       Impact factor: 3.575

2.  Testing vigilance: validity, reliability and sensitivity in methods development.

Authors:  M Sarter; P J Bushnell
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

3.  Cyclohexane produces behavioral deficits associated with astrogliosis and microglial reactivity in the adult hippocampus mouse brain.

Authors:  Tania Campos-Ordonez; David Zarate-Lopez; Alma Y Galvez-Contreras; Norma Moy-Lopez; Jorge Guzman-Muniz; Oscar Gonzalez-Perez
Journal:  Cell Mol Neurobiol       Date:  2014-11-30       Impact factor: 5.046

4.  Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™.

Authors:  Jean G Sathish; Siddhartha Bhatt; Jamie K DaSilva; Declan Flynn; Stephen Jenkinson; Amit S Kalgutkar; Maggie Liu; Balasubramanian Manickam; Jason Pinkstaff; William J Reagan; Norimitsu Shirai; Ahmed M Shoieb; Madhu Sirivelu; Saurabh Vispute; Allison Vitsky; Karen Walters; Todd A Wisialowski; Lawrence W Updyke
Journal:  Int J Toxicol       Date:  2022-05-21       Impact factor: 2.380

5.  Behavioral effects induced by acute exposure to benzo(a)pyrene in F-344 rats.

Authors:  C R Saunders; D C Shockley; M E Knuckles
Journal:  Neurotox Res       Date:  2001-11       Impact factor: 3.911

6.  Vision evaluation by functional observational battery, operant behavior test, and light/dark box test in retinal dystrophic RCS rats versus normal rats.

Authors:  Toshihiko Matsuo; Tetsuya Uchida; Koichiro Yamashita; Shigiko Takei; Daisuke Ido; Atsushi Fujiwara; Masahiko Iino; Masao Oguchi
Journal:  Heliyon       Date:  2019-06-20

Review 7.  Issues in the design, analysis, and application of rodent developmental neurotoxicology studies.

Authors:  Charles V Vorhees; Michael T Williams
Journal:  Neurotoxicol Teratol       Date:  2021-07-10       Impact factor: 4.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.